💊 दवाएँ A-Z 🧬 लक्ष्य 🛠 उपकरण 📚 मार्गदर्शिकाएँ
सभी दवाएँ दवा वर्ग चिकित्सीय क्षेत्र दुष्प्रभाव
मार्गदर्शिकाएँ शब्दकोश समयरेखा
तुलनाएँ दवाओं की यात्राएँ दवा परिवार
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Sodium Nitroprusside

CHEMBL136478 Phase 4 अनुमोदित Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
261.9 g/mol
LogP
—
Phase
4

Administered through an intravenous drip in critical care settings, this potent vasodilator instantly relaxes blood vessel walls to bring down dangerously high blood pressure or reduce the workload on a failing heart. Its effects begin within seconds and stop almost immediately when the infusion is slowed, allowing precise minute-by-minute blood pressure control.

आणविक भार

261.9200 g/mol

TPSA

144.00 Ų

चिकित्सीय क्षेत्र

अग्नाशय कैंसर उच्च रक्तचाप एट्रियल फ़िब्रिलेशन ओवेरियन कैंसर कोलोरेक्टल कैंसर क्रॉनिक ऑब्सट्रक्टिव पल्मोनरी डिज़ीज़ (COPD) क्रॉनिक किडनी डिज़ीज़ ग्लूकोमा टाइप 2 मधुमेह थायरॉइड कैंसर नॉन-स्मॉल सेल लंग कैंसर प्रोस्टेट कैंसर मूत्राशय कैंसर मोटापा लिम्फोमा ल्यूकेमिया सिज़ोफ्रेनिया स्ट्रोक स्तन कैंसर हाइपरलिपिडेमिया हृदय विफलता हृदय-संवहनी रोग

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.N#[O+].[Na+].[Na+].[Fe+2]

InChI

InChI=1S/5CN.Fe.NO.2Na/c5*1-2;;1-2;;/q5*-1;+2;3*+1

Molecular Formula

C5FeN6Na2O

HBD / HBA

- / 11

घूर्णनीय बंधन

0

भारी परमाणु

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

Administered through an intravenous drip in critical care settings, this potent vasodilator instantly relaxes blood vessel walls to bring down dangerously high blood pressure or reduce the workload on a failing heart. Its effects begin within seconds and stop almost immediately when the infusion is slowed, allowing precise minute-by-minute blood pressure control.

Yes, Sodium Nitroprusside is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL136478. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6604165. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.